Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Automated Home Blood Pressure Monitors market in this environment.
In terms of revenue, this research report indicated that the global Automated Home Blood Pressure Monitors market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Automated Home Blood Pressure Monitors industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The OMRON aims at producing XX K Units Automated Home Blood Pressure Monitors in 2020, with XX % production to take place in global market, A&D accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Automated Home Blood Pressure Monitors Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Automated Home Blood Pressure Monitors Market
OMRON
A&D
Microlife
NISSEI
Panasonic
Welch Allyn
Yuwell
Beurer
Citizen
Andon
Rossmax
Bosch + Sohn
Homedics
Kingyield
Sejoy
...
Major Type of Automated Home Blood Pressure Monitors Covered in Prudent Markets report:
Upper Arm Blood Pressure Monitor
Wrist Blood Pressure Monitor
Other
Application Segments Covered in Prudent Markets Market
Offline
Online
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Automated Home Blood Pressure Monitors Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Upper Arm Blood Pressure Monitor -Product Introduction and Major Manufacturers
1.1.2 Wrist Blood Pressure Monitor -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Automated Home Blood Pressure Monitors Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Automated Home Blood Pressure Monitors Market
3.1.1 Top Companies leading Automated Home Blood Pressure Monitors Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Automated Home Blood Pressure Monitors Market
3.2.1 Top Companies leading Automated Home Blood Pressure Monitors Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Automated Home Blood Pressure Monitors Market
3.3.1 Top Companies leading Automated Home Blood Pressure Monitors Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Automated Home Blood Pressure Monitors Market
3.4.1 Top Companies leading Automated Home Blood Pressure Monitors Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Automated Home Blood Pressure Monitors Market
3.5.1 Top Companies leading Automated Home Blood Pressure Monitors Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Automated Home Blood Pressure Monitors Market
3.6.1 Top Companies leading Automated Home Blood Pressure Monitors Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Automated Home Blood Pressure Monitors Market
3.7.1 Top Companies leading Automated Home Blood Pressure Monitors Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Automated Home Blood Pressure Monitors Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Automated Home Blood Pressure Monitors Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Automated Home Blood Pressure Monitors Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Automated Home Blood Pressure Monitors Sales and Growth Rate (2021-2027)
5.2 Global Automated Home Blood Pressure Monitors Sales Value and Growth Rate (2021-2027)
6 Automated Home Blood Pressure Monitors Competitive Analysis
6.1 OMRON
6.1.1 OMRON Company Profiles
6.1.2 OMRON Product Introduction
6.1.3 OMRON Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 A&D
6.2.1 A&D Company Profiles
6.2.2 A&D Product Introduction
6.2.3 A&D Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Microlife
6.3.1 Microlife Company Profiles
6.3.2 Microlife Product Introduction
6.3.3 Microlife Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 NISSEI
6.4.1 NISSEI Company Profiles
6.4.2 NISSEI Product Introduction
6.4.3 NISSEI Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Panasonic
6.5.1 Panasonic Company Profiles
6.5.2 Panasonic Product Introduction
6.5.3 Panasonic Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Welch Allyn
6.6.1 Welch Allyn Company Profiles
6.6.2 Welch Allyn Product Introduction
6.6.3 Welch Allyn Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Yuwell
6.7.1 Yuwell Company Profiles
6.7.2 Yuwell Product Introduction
6.7.3 Yuwell Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Beurer
6.8.1 Beurer Company Profiles
6.8.2 Beurer Product Introduction
6.8.3 Beurer Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Citizen
6.9.1 Citizen Company Profiles
6.9.2 Citizen Product Introduction
6.9.3 Citizen Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Andon
6.10.1 Andon Company Profiles
6.10.2 Andon Product Introduction
6.10.3 Andon Automated Home Blood Pressure Monitors Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Rossmax
6.12 Bosch + Sohn
6.13 Homedics
6.14 Kingyield
6.15 Sejoy
7 Conclusion